Toll-like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
Crossref DOI link: https://doi.org/10.2119/molmed.2014.00076
Published Online: 2014-10-31
Published Print: 2014-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McDonald, Kerry-Ann
Huang, Hai
Tohme, Samer
Loughran, Patricia
Ferrero, Kimberly
Billiar, Timothy
Tsung, Allan
Text and Data Mining valid from 2014-01-01
Article History
Received: 17 April 2014
Accepted: 20 October 2014
First Online: 31 October 2014